Article
Malignant Transformation Involving CXXC4 Mutations Identified in a Leukemic Progression Model of Severe Congenital Neutropenia.
Cell reports. Medicine - 25 Aug 2020
Olofsen Patricia A, Fatrai Szabolcs, van Strien Paulina M H, Obenauer Julia C, de Looper Hans W J, Hoogenboezem Remco M, Erpelinck-Verschueren Claudia A J, Vermeulen Michael P W M, Roovers Onno, Haferlach Torsten, Jansen Joop H, Ghazvini Mehrnaz, Bindels Eric M J, Schneider Rebekka K, de Pater Emma M, Touw Ivo P
Abstract excerpt
Severe congenital neutropenia (SCN) patients treated with CSF3/G-CSF to alleviate neutropenia frequently develop acute myeloid leukemia (AML). A common pattern of leukemic transformation involves the appearance of hematopoietic clones with CSF3 receptor (CSF3R) mutations in the neutropenic phase, followed by mutations in RUNX1 before AML becomes overt. To investigate how the combination of CSF3 therapy and CSF3R...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
